Colorectal Cancer Screening Aims To Detect Symptoms Of Cancer Early Making It Easier For Treatment

Colorectal Cancer Screening

Colorectal cancer is the second most common cancer in the United States. It can be prevented with regular Colorectal Cancer Screening. Many people do not realize that they are at risk as the symptoms of colon cancer can be similar to those of other conditions such as constipation or irritable bowel syndrome. The symptoms can take a long time to develop.

A number of factors can increase the chance of getting colorectal cancer, including age, race, and a diet low in fiber and high in fat, especially from animal sources. A lack of exercise, smoking and heavy alcohol use can also raise the risk.

The Colorectal Cancer Screening Market was estimated at US$12,866.16 billion in 2021 and is anticipated to grow at a 7.5% CAGR from 2022 to 2028 to reach US$21,135.40 billion.

Doctors can check for colon cancer with a physical exam and by pressing on the belly area. They can also do a stool sample, which looks for signs of cancer, such as blood in the stool.

Symptoms of colon cancer can include abdominal pain or a feeling of fullness, blood in stool. These symptoms can vary depending on the stage of cancer and where it spreads.

Almost all colon cancers start in the large intestine, also called the colon. Regular screening can find precancerous polyps or early cancers, and allow them to be removed before they can turn into cancer. Colorectal Cancer Screening also finds symptoms early, when they are usually easier to treat.

Screening tests look for changes in the stool that may be signs of precancerous polyps or colorectal cancer. Some screening tests are done at home, while others require a visit to a doctor's office. Different screening tests have different risks and benefits.

Doctors will recommend a screening test will depend on patient’s age, family history of colorectal cancer, and other health conditions. Some people may need screening more often than others.

The most common types of Colorectal Cancer Screening are stool-based tests. These include fecal occult blood tests and stool color and shape tests. These tests can help the doctor find hidden blood in stools, which is sometimes the first and only warning sign of colorectal cancer or precancerous polyps.

Other colorectal cancer screen tests use direct visualization of the colon and rectum or special imaging tests. These tests are done with a scope put in through the anus, or by using a CT scan to take 2- or 3-D pictures of the colon and rectum. These tests can show more details than stool-based testing, as they can have some risks.

Some types of Colorectal Cancer Screening tests can be done at home, while other testing needs to be done in the doctor's office or hospital. A doctor will recommend a suitable screening test.

A US-based biopharmaceutical company Merck & Co., Inc., has acquired VelosBio, Inc., in November 2020, for $2.75 billion. This acquisition will strengthen Merck’s oncology drug pipeline with VLS-101 for treating patients suffering with solid tumors and hematologic malignancies.